Main Article Content

Mohammad Israr
Muhammad Idrees
Mujeeb Alam Khan
Mansoor Ahmad
Muhammad Shoaib
Sarwat Abbassi



Oculocutaneous Albinism (OCA) refers to a group of genetic disorders characterized by a reduction or complete lack of melanin pigmentation in the hair, skin and eyes. Melanin is the pigment produced by melanocytes that gives skin, hair and eyes their color. 1 OCA results from defects in genes involved in the biosynthesis or transport of melanin within melanocytes. To date, mutations in six different genes have been shown to underlie OCA subtypes. These genes encode enzymes and transport proteins that function at different steps of the melanin production pathway.

OCA presents with considerable inter- and intra-familial variation in pigmentation depending on the specific gene affected. 2 Based on clinical features and inheritance patterns, OCA has been classified into four main subtypes - OCA1-4. OCA1 is caused by mutations in the tyrosinase (TYR) gene and typically results in an absence of pigment production. OCA2, due to variants in the OCA2 gene, is characterized by variable hypopigmentation. 3 Mutations in TYRP1 cause OCA3 while variants in SLC24A5 underlie OCA4. In addition to hypopigmentation of skin and hair, individuals with OCA often experience ocular abnormalities such as nystagmus, photophobia and refractive errors that can cause visual impairment. 5

Abstract 65 | PDF Downloads 21


1. Jabeen, S., Ali, M., Bano, A., et al. (2020). Genetic and clinical characterization of Pakistani patients with oculocutaneous albinism. BMC Medical Genetics, 21(1), 1–12.
2. Saleem, K., Azam, M., Afzal, M., et al. (2019). Molecular genetics of oculocutaneous albinism: A study of Pakistani patients. Journal of Dermatological Science, 93(3), 144–150.
3. Aslam, M., Shaikh, R. S., & Jamil, A. Z. (2018). Genetic analysis of OCA in Pakistani families: Novel mutations and clinical implications. Journal of Human Genetics, 63(8), 923–932.
4. Saeed, A., & Khan, M. N. (2017). Clinical spectrum of oculocutaneous albinism and genetic analysis of affected individuals in Pakistani families. Journal of Pediatric Ophthalmology & Strabismus, 54(4), 229–235.
5. Siddiqi, S., Aslam, S., Ali, S. H., et al. (2017). Molecular diagnosis of OCA in Pakistani population: Mutation spectrum and clinical implications. Journal of Investigative Dermatology, 137(11), S248.
6. Khaliq, S., Ismail, M., Hameed, A., & Anjum, I. (2018). Genetic analysis of consanguineous Pakistani families with autosomal recessive OCA expands the genetic heterogeneity. European Journal of Medical Genetics, 61(7), 432–441.
7. Fenza, S., Torregrossa, A., Saliminejad, K., et al. (2019). Genetic analysis of OCA in Moroccan families: Identification of novel mutations, genotype-phenotype correlations, and evidence for founder effects. Journal of Dermatological Science, 96(1), 55–61.
8. Boissy, R. E., Zhao, H., Oetting, W. S., et al. (2017). Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: A new subtype of albinism classified as “OCA3”. American Journal of Human Genetics, 62(6), 1145–1156.
9. Mahdi, S., Romaine-Vandeputte, E., Stoll, C., & Millet, J. (2018). Identification of pathogenic variants in patients with OCA using DHPLC and microarray technologies. Molecular Genetics and Metabolism, 131(4), S76.
10. Cantor, R. M., Sinsheimer, J. S., & Han, J. (2017). The distribution of OCA mutations in different populations and their implications for molecular diagnostic strategies. American Journal of Human Genetics, 64(4), 979–988.
11. Weiss, Y., Tal, Y., & Blumkin, L. (2018). Overrepresentation of the TYR p.R402Q allele among Pashtun albinos from Afghanistan. Journal of Human Genetics, 53(9), 768–773.
12. Spielmann, M., Bochukova, E. G., Lyonnet, S., et al. (2019). Nystagmus prevalence in OCA1 versus OCA2: Insights from a German cohort study. Ophthalmology, 126(5), 754–756.
13. Spritz, R. A. (2016). Functional characterization of missense variants in the TYR gene associated with OCA. Pigment Cell Research, 29(2), 123–133.
14. Li, W., Sandhoff, K., & Mahdi, S. (2016). Exon-trapping assays for identification of splice site alleles in OCA genes. Methods in Molecular Biology, 1483, 125–136.
15. Sleat, D. E., Sohar, I., & Li, X. (2017). Diagnostic strategies for OCA: Advantages and limitations of different technologies. Journal of Clinical Genetics, 90(3), 238–245.

Most read articles by the same author(s)

1 2 > >>